Valhi

VHI

Börsenwert 416 Mio. $

Dallas, Texas, Oct. 14, 2026 (GLOBE NEWSWIRE) -- Valhi, Inc. (NYSE:  VHI) announced today that, subject to the completion of quarter-end closing procedures, it expects to report third quarter 2026 earnings in a press release after market close on Thursday, November 5, 2026.

VHI's Q2 earnings jump y/y as higher TiO2 volumes, lower costs and wider margins lift the results, supporting an improved 2026 operating outlook.

Dallas, Texas, Aug. 06, 2026 (GLOBE NEWSWIRE) -- Valhi, Inc. (NYSE: VHI) reported net income attributable to Valhi stockholders of $22.3 million, or $.78 per share, in the second quarter of 2026 compared to net income of $.9 million, or $.03 per share, in the second quarter of 2025. For the first six months of 2026, Valhi reported net income attributable to Valhi stockholders of $24.3 million, or $.85 per share, compared to $17.8 million, or $.62 per share, in the first six months of 2025. Net income attributable to Valhi stockholders increased in the second quarter of 2026 as compared to the same period of 2025 primarily due to higher operating results from the Chemicals Segment. Net income attributable to Valhi stockholders increased in the first six months of 2026 as compared to the same period of 2025 primarily due to improved operating results across all business segments.

Dallas, Texas, Aug. 06, 2026 (GLOBE NEWSWIRE) -- Valhi, Inc. (NYSE:  VHI) announced today that its board of directors has declared a regular quarterly dividend of eight cents ($0.08) per share on its common stock, payable on September 24, 2026 to stockholders of record at the close of business on September 3, 2026.

Dallas, Texas, July 14, 2026 (GLOBE NEWSWIRE) -- Valhi, Inc. (NYSE:  VHI) announced today that, subject to the completion of quarter-end closing procedures, it expects to report second quarter 2026 earnings in a press release after market close on Thursday, August 6, 2026.

Valhi trades at a ~36% NAV discount, but we believe there is no clear catalyst for closure. Q2 faces margin pressure from higher energy costs in VHI's chemicals segment, which we expect will be at least partially offset by rising TiO2 prices. End-market demand, especially in property and homebuilding, remains a concern and will likely reflect in ongoing economics, limiting upside for VHI's core products.

Discover why Zacks, being the first on Wall Street to initiate coverage of the stock, rates Valhi as "Underperform." Explore how VHI's pricing pressure, weak demand and rising costs could weigh on earnings and limit upside potential.

TORONTO, June 16, 2026 (GLOBE NEWSWIRE) -- Vitalhub Corp. (TSX:VHI) (OTCQX:VHIBF) (the “Company” or “VitalHub”) announced today that Novari Health, a VitalHub company, has executed agreements to implement wait list and referral management software technologies at Sunnybrook Health Sciences Centre and across the northern region of British Columbia. Sunnybrook joins hospitals, regional health authorities, and health systems in Canada, Australia and the United Kingdom that have implemented Novari solutions to improve access to care. The Novari solutions are being leveraged in British Columbia to help modernize the region's delivery of surgical, diagnostic imaging, and laboratory services.

Dallas, Texas, May 21, 2026 (GLOBE NEWSWIRE) -- Valhi, Inc. (NYSE:  VHI) announced today that its board of directors has declared a regular quarterly dividend of eight cents ($0.08) per share on its common stock, payable on June 25, 2026 to stockholders of record at the close of business on June 4, 2026.

Vitalhub Corp. (VHI:CA) Q1 2026 Earnings Call Transcript